Health-related Quality of Life and Functional Impairments After Intensive Care Unit Discharge
CritiQoL2
1 other identifier
observational
500
1 country
1
Brief Summary
Diagnostic and therapeutic progress of the last twenty years has been accompanied by an evolution in the morbidity and mortality of intensive care unit (ICU) patients. While there has been an overall decrease in mortality in the ICU, nearly 20% of patients die within one year after ICU discharge and survivors are marked by an increase in morbidity. Indeed, independently of the initial disease, it is currently recognized that an admission to the ICU can be experienced as a traumatic situation, with potential physical, psychological and cognitive impairments that can be described by the term "post-intensive care syndrome" (PICS). This results in a decrease in quality of life compared to the general population. Health-related quality of life (HRQoL)has received increasing attention in the literature. Thus, many studies have been interested in its evaluation, in particular in certain pathologies such as acute respiratory distress syndrome (ARDS), sepsis, cardiac arrest or in patients with onco-hematological diseases. Paradoxically, few studies have described the HRQoL and the elements of the PICS in the overall population of patients admitted to the ICU. However, a better understanding of these elements could allow us to propose improvement strategies to facilitate the rehabilitation of these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2021
CompletedFirst Posted
Study publicly available on registry
November 8, 2021
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedJuly 27, 2022
July 1, 2022
3 years
September 28, 2021
July 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of an overall HRQOL and ii) percentage functional impairments in the global population of intensive care unit survivors,2 years after ICU discharge.according to the score to following scales :
i)36-Item Short Form Survey (SF-36) (HRQoL)-Ranging score\[0-100\], a high score indicate better health status. ii)The Glasgow Outcome Scale extended (Handicap)-Ranging score\[1-8\] a hight score indicate no handicap. Barthel index (Dependency)-Ranging score\[0-100\], a high score indicate no dependency. The Fatigue Severity Scale(fatigue)-Ranging score\[9-63\],a high score indicate a greater fatigue severity. The Hospital anxiety and depression (Anxiety,Depression)-Ranging score\[0-21\] a score \> 8 indicate in each subscale a depresion or/and anxiety The Impact of Event Scale -Revised(post traumatic syndrome disorder)-Ranging score\[0-88\],scores higher than 24 are of concern; the higher scores indicate the severity of PTSD The Montreal Cognitive Assessment (MoCA)(Cognition)-Ranging score\[0-30\] a score of 26 and higher generally is considered normal or Telephone MoCA-Ranging score\[0-22\],a score of 18 and higher generally is considered normal.
24month
Secondary Outcomes (1)
Presence or not of elements associated with i) HRQOL impairements defined by ii)physical and/or psychological and /or cognitive impairments in the global population and in differents sub-groups of interest, according to the to following scales :
24 month
Eligibility Criteria
all patients who meet the eligibility criteria will be offered participation in the study.
You may qualify if:
- all adult patients(age\>18) hospitalized in ICU
You may not qualify if:
- legal guardianship
- opposition to participate
- unread and unwritten French language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Versailles Hospitallead
- Legriel Stéphanecollaborator
Study Sites (1)
Versailles hospital
Le Chesnay, France
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Gwenaëlle JACQ, RN,MSc
Versailles Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
September 28, 2021
First Posted
November 8, 2021
Study Start
January 1, 2023
Primary Completion
January 1, 2026
Study Completion
January 1, 2026
Last Updated
July 27, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share